Gene therapy stocks surge on Roche-Spark deal
February 25, 2019 at 09:28 AM EST
Shares of gene therapy companies surged in premarket trade Monday, buoyed by the news of Roche Holding AG’s acquisition of Spark Therapeutics Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|